Continuing Education credits

CME Credits for Physicians

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Professional Education Services Group (PESG) and the Alzheimer’s Association. Professional Education Services Group is accredited by the ACCME to provide continuing medical education for physicians.

Professional Education Services Group designates this conference for a maximum of 25.5 AMA PRA category 1 Credits™. Each physician should claim only those credits that he/she actually spent in the activity.

Professional Education Services Group designates the Alzheimer’s Imaging Consortium pre-conference for up to 6.0 AMA PRA Category 1 Credits™. Each physician should claim only those credits that he/she actually spent in the activity.

back to top

CE for Psychologists

The Alzheimer’s Association is approved by the American Psychological Association to sponsor continuing education for psychologists. The Alzheimer’s Association maintains responsibility for this program and its content. There are up to 25.5 continuing education credit hours available for psychologists for the conference and up to 6.0 credits available for the Alzheimer’s Imaging Consortium pre-conference. Psychologists should only claim credit commensurate with the extent of their participation in the activity.

back to top

Obtaining CE/CME

Participants who qualify for continuing education credits must pay a $55 registration fee ($45 for ISTAART members) for each professional certificate, complete an attendance form and claim credit only for sessions attended, and complete the appropriate evaluation forms to receive continuing education credits.

Sign up for continuing education credit when you register for the conference. When you arrive at the registration area at the conference, pick up a Continuing Education Packet at the Continuing Education Desk, complete all relevant forms, and return them to the desk before you leave or mail them as instructed.

back to top

Statement of Need, Purpose and Objective

The Alzheimer’s Association International Conference on Alzheimer’s Disease is organized to foster interdisciplinary interactions among health care, research, clinical and administrative professionals concerned with aging and Alzheimer’s disease. In addition to the core plenary and symposia sessions, oral and poster sessions will be presented to encourage and stimulate diverse viewpoints in research, treatment and care.

back to top

The 2008 Conference will focus on:

• Advances in imaging and other techniques to improve diagnosis and the understanding of disease progression
• Optimal use of existing therapies, often in combination regimens, that aim to manage the cognitive and neurobehavioral deficits in patients with Alzheimer’s disease
• New Information relating to the currently off-label use of atypical antipsychotic drugs in patients with Alzheimer’s disease, emphasizing dosing, safety and potential drug-drug interactions
• Further elucidation of the pathophysiology of aging, Alzheimer’s disease, and other geriatric syndromes, including potential targets for therapy as well as recommendations for prevention
• Therapeutic breakthroughs in Alzheimer’s disease and innovative strategies on the horizon
• Acute and long-term issues relating to the burden of illness on individuals and caregivers, socioeconomic concerns, and research and ethics

back to top

Target Audience

This conference is targeted to:

• Biochemists
• Geriatric psychiatrists
• Geriatric specialists
• Molecular/cell biologists
• Primary care physicians
• Neurologists
• Neuroscientists
• Pharmacologists
• Psychiatrists
• Psychologists
• Radiologists

back to top

Learning Objectives

At the conclusion of this conference, participants should be able to:

• Identify and explaining advances in imaging, biomarkers, and other techniques to improve diagnosis and monitor disease progression
• Discuss data on current animal models for Alzheimer’s disease
• Compare the pathophysiology of aging, Alzheimer’s disease and other geriatric syndromes, and identify potential targets for therapy as well as recommendations for prevention
• Explain therapeutic breakthroughs in neurodegenerative diseases and emerging strategies likely to drive future advances
• Identify immediate and long-term issues relating to the burden of illness on patients and caregivers, health economics concerns, and research and ethics

back to top